Company Information

DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE221.251.95 (+0.89 %)
PREV CLOSE ( ) 219.30
OPEN PRICE ( ) 214.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 32616
TODAY'S LOW / HIGH ( )213.45 224.15
52 WK LOW / HIGH ( )113.25 282.95
NSE221.051.5 (+0.68 %)
PREV CLOSE( ) 219.55
OPEN PRICE ( ) 217.00
BID PRICE (QTY) 221.05 (53)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 383540
TODAY'S LOW / HIGH( ) 213.40 224.15
52 WK LOW / HIGH ( )113.1 283
ChairmanJanmejay R Vyas
Managing DirectorArpit J Vyas
Company SecretaryShrima G Dave
Non Executive Independent DirectorSubir Kumar Das
Rajendra S Shah
Maitri Mehta
Whole Time DirectorDeohooti J Vyas
Incorporation Year : 2007

Registered Office :

Address : Dishman Corporate House,Iscon - Bopal Road,Ambli Ahmedabad,
Gujarat-380058 .

Phone : 02717 420102 / 124

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.